Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)
about
A case report of primary cutaneous natural killer/T-cell lymphoma.Early disease progression in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.Short-Course Versus Long-Course Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T cell Lymphoma, Nasal Type: A Multicenter Retrospective Study.
P2860
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Phase II trial of concurrent c ...... mphoma, nasal type (CISL-1008)
@en
Phase II trial of concurrent c ...... phoma, nasal type (CISL-1008).
@nl
type
label
Phase II trial of concurrent c ...... mphoma, nasal type (CISL-1008)
@en
Phase II trial of concurrent c ...... phoma, nasal type (CISL-1008).
@nl
prefLabel
Phase II trial of concurrent c ...... mphoma, nasal type (CISL-1008)
@en
Phase II trial of concurrent c ...... phoma, nasal type (CISL-1008).
@nl
P2093
P2860
P921
P356
P1433
P1476
Phase II trial of concurrent c ...... mphoma, nasal type (CISL-1008)
@en
P2093
Cheolwon Suh
Deok-Hwan Yang
Dok Hyun Yoon
Dong-Yeop Shin
Ho-Young Yhim
Hye Jin Kang
Hyeon-Seok Eom
Hyewon Lee
Jae Hoon Lee
Jae-Yong Kwak
P2860
P304
85584-85591
P356
10.18632/ONCOTARGET.11319
P407
P577
2016-08-16T00:00:00Z